Suppr超能文献

冠状动脉解剖结构和心肌缺血对稳定型缺血性心脏病患者长期生存的影响。

Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.

作者信息

Weintraub William S, Hartigan Pamela M, Mancini G B John, Teo Koon K, Maron David J, Spertus John A, Chaitman Bernard R, Shaw Leslee J, Berman Daniel, Boden William E

机构信息

MedStar Heart & Vascular Institute, Georgetown University, Washington, DC (W.S.W.).

VA Connecticut Healthcare System, West Haven (P.M.H.).

出版信息

Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005079. doi: 10.1161/CIRCOUTCOMES.118.005079.

Abstract

Background The severity of coronary artery disease (CAD) and of ischemia are evaluated to guide therapy, but their relative prognostic importance remains uncertain. Accordingly, we sought to clarify their association with long-term survival in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). Methods and Results Survival data from after the original trial period ended was obtained at 15 Veterans Affairs sites and 13 of 18 United States non-Veterans Affairs sites. Date of death was obtained from the Veterans Affairs system-wide Corporate Data Warehouse and the National Death Index. Of the original 2287 patients in COURAGE, 1370 (60%) had both stress perfusion imaging and quantitative coronary angiography available, with extended survival evaluated in 767 subjects. Survival was calculated by the Kaplan-Meier method, and a Cox proportional-hazards model adjusted for baseline differences. There were 369 all-cause deaths during a median follow-up of 7.9 years (range, 0-15 years). The number of coronary arteries diseased predicted survival (HR, 1.25; 95% CI, 1.09-1.43), whereas severity of ischemia did not (HR, 0.99; 95% CI, 0.80-1.22). Percutaneous coronary intervention did not offer a survival advantage over optimal medical therapy (HR, 0.95; 95% CI, 0.77-1.16) and there was no interaction between therapeutic strategy and number of coronary arteries diseased or severity of ischemia. In fully adjusted models, the number of coronary arteries diseased was not associated with increased mortality. Conclusions In univariate analysis, the number of coronary arteries diseased predicted long-term mortality, but severity of ischemia did not. Adjusted for baseline variables, neither assessment approach predicted mortality. Overall, there was no survival benefit from percutaneous coronary intervention in any subset defined by either angiographic or ischemic severity. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00007657.

摘要

背景 评估冠状动脉疾病(CAD)的严重程度和缺血情况以指导治疗,但其相对的预后重要性仍不确定。因此,我们试图在“勇气”试验(利用血运重建和积极药物评估的临床结果)中阐明它们与长期生存的关联。方法与结果 在15个退伍军人事务部站点以及18个美国非退伍军人事务部站点中的13个站点获取了原始试验期结束后的生存数据。死亡日期来自退伍军人事务部全系统的企业数据仓库和国家死亡索引。在“勇气”试验最初的2287名患者中,1370名(60%)具备负荷灌注成像和定量冠状动脉造影资料,对767名受试者进行了延长生存期评估。采用Kaplan-Meier方法计算生存率,并使用Cox比例风险模型对基线差异进行校正。在中位随访7.9年(范围0至15年)期间,共有369例全因死亡。病变冠状动脉的数量可预测生存情况(风险比[HR],1.25;95%置信区间[CI],1.09至1.43),而缺血严重程度则不能(HR,0.99;95%CI,0.80至1.22)。经皮冠状动脉介入治疗相比最佳药物治疗并未提供生存优势(HR,0.95;95%CI,0.77至1.16),且治疗策略与病变冠状动脉数量或缺血严重程度之间不存在相互作用。在完全校正的模型中,病变冠状动脉的数量与死亡率增加无关。结论 在单变量分析中,病变冠状动脉的数量可预测长期死亡率,但缺血严重程度则不能。校正基线变量后,两种评估方法均不能预测死亡率。总体而言,在由血管造影或缺血严重程度定义的任何亚组中,经皮冠状动脉介入治疗均未带来生存获益。临床试验注册:网址:https://www.clinicaltrials.gov 。唯一标识符:NCT00007657

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验